https://www.marketscreener.com/quote/stock/LIXTE-BIOTECHNOLOGY-HOLDI-302255/news/LIXTE-Provides-Update-on-Progress-with-LB-100-as-a-PP2A-Inhibitor-to-Enhance-Chemotherapy-and-Immuno-46252687/?utm_source=telegram&utm_medium=social&utm_campaign=share